You are here: Industry Insights > Alzheimer

News List

Alzheimer's disease might be a 'whole body' problem worldpharmanews
November 01, 2017
Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scientists indicates that ...
Researchers identify ineffectiveness of Alzheimer’s drug semagacestat europeanpharmaceuticalreview
October 27, 2017
Scientists have found that some potential γ-secretase inhibitors such as semagacestat, do not function as true inhibitors as originally expected…
Eisai banks on potential of Biogen’s Alzheimer’s drug pharmafile
October 25, 2017
Drug developers investigating Alzheimer’s drugs know that they’re taking a gamble; there have been numerous big failures that have caused larger companies to shy away from the difficult-to-treat area.
Axovant shares capitulate after Alzheimer’s drug failure pharmafile
September 27, 2017
Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that.
Alzheimer’s Disease: Greatest Threat to Healthy Aging biospectrumasia
September 06, 2017
According to a report by Alzheimer’s Disease International (ADI) titled ‘Dementia in the Asia Pacific Region’ the number of people with dementia in the region will increase from 23 million in 2015 to almost 71 million by 2050.
Heptares doses first subject in Alzheimer’s drug trial pharmatimes
September 04, 2017
London, UK-based Heptares Therapeutics says the first healthy subject has now been dosed with its first-in-class, selective muscarinic M4 receptor agonist HTL0016878 in a Phase I clinical study.
Machine-learning program shows promise for Alzheimer’s diagnosis europeanpharmaceuticalreview
August 18, 2017
Researchers have developed a new machine-learning program that appears to outperform other methods for diagnosing Alzheimer’s disease…
Alzheimer's Drugs Market is expected to Rise to US$6.4 Billion by 2025 americanpharmaceuticalreview
August 10, 2017
According to Transparency Market Research (TMR), the global Alzheimer's Drugs Market is expected to exhibit a consistent 7.5% CAGR in the 2017-2025 forecast period. The market's revenue was valued at more than US$3.6 bn in 2017 and is expected to rise to
Cellular ‘garbage disposal’ units fingered in Alzheimer’s development fiercebiotech
August 08, 2017
Scientists at Yale University are zeroing in on lysosomes in the brain, and they believe they’ve discovered how these “garbage disposal” units may contribute to the buildup of the amyloid plaques characteristic of Alzheimer’s disease.
Stomach acid drugs do not increase Alzheimer's risk, study confirms pharmafile
August 08, 2017
A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as lansoprazole and omeprazole do not increase the risk of developing Alzheimer’s disease...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page